Trademark: 90285221
Word
3RDEYEBIO
Status
Registered
Status Code
700
Status Date
Tuesday, March 22, 2022
Serial Number
90285221
Registration Number
6675094
Registration Date
Tuesday, March 22, 2022
Mark Type
4000
Filing Date
Wednesday, October 28, 2020
Published for Opposition
Tuesday, January 4, 2022

Trademark Owner History
3RDEYEBIO LLC - Original Registrant

Classifications
35 Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
42 Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenomics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning application; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer, stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
THIRD EYE BIO

Trademark Events
Mar 22, 2022
Registered-Principal Register
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Dec 1, 2021
Approved For Pub - Principal Register
Dec 1, 2021
Examiner's Amendment Entered
Dec 1, 2021
Notification Of Examiners Amendment E-Mailed
Dec 1, 2021
Examiners Amendment E-Mailed
Dec 1, 2021
Examiners Amendment -Written
Jul 1, 2021
Notification Of Letter Of Suspension E-Mailed
Jul 1, 2021
Letter Of Suspension E-Mailed
Jul 1, 2021
Suspension Letter Written
Jun 1, 2021
Teas/Email Correspondence Entered
Jun 1, 2021
Correspondence Received In Law Office
Jun 1, 2021
Teas Response To Office Action Received
Apr 3, 2021
Notification Of Non-Final Action E-Mailed
Apr 3, 2021
Non-Final Action E-Mailed
Apr 3, 2021
Non-Final Action Written
Mar 29, 2021
Assigned To Examiner
Dec 20, 2020
New Application Office Supplied Data Entered In Tram
Nov 1, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24